Renalytix AI

About:

RenalytixAI is a developer of artificial intelligence-enabled clinical diagnostic solutions for kidney health.

Website: https://renalytix.com

Twitter/X: Renalytix

Top Investors: Horizon Europe, DB Capital Partners, Christopher Mills, Ann E. Berman, Thomas McLain

Description:

RenalytixAI is a developer of artificial intelligence (AI) enabled clinical diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAI’s solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care, and patient stratification for drug clinical trials. RenalytixAI’s technology platform will draw from distinct sources of patient data, including large electronic health records, predictive blood-based biomarkers, and other genomic information for analysis by learning computer algorithms. RenalytixAI intends to build a deep, unique pool of kidney disease-related data for different AI-enabled applications designed to improve predictive capability and clinical utility over time.

Total Funding Amount:

$78.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Penarth, Vale of Glamorgan, The, United Kingdom

Founded Date:

2018-01-01

Contact Email:

renalytix(AT)walbrookpr.com

Founders:

Girish Nadkarni, James R. McCullough, Steven Coca

Number of Employees:

101-250

Last Funding Date:

2024-04-08

IPO Status:

Public

© 2024 MyAiNote.com